These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6212259)

  • 21. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
    Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
    Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
    Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR
    Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of total lymphoid irradiation on natural killer cells and cytotoxic and primed T lymphocytes.
    Weiss L; Slavin S
    Isr J Med Sci; 1994 Apr; 30(4):253-9. PubMed ID: 8175324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK activity in carrageenan-treated mice.
    Quan PC; Kolb JP; Lespinats G
    Immunology; 1980 Aug; 40(4):495-503. PubMed ID: 6159311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
    Savary CA; Lotzová E
    J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Res; 1983 Nov; 43(11):5240-3. PubMed ID: 6225513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer activity of gut mucosal lymphoid cells in mice.
    Tagliabue A; Luini W; Soldateschi D; Boraschi D
    Eur J Immunol; 1981 Nov; 11(11):919-22. PubMed ID: 7327195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of major histocompatibility complex antigens and inhibition of proliferative activity of YAC lymphoma cells by a natural killer lysis resistance-inducing factor (NK-LRIF).
    Saxena RK; Chrest FJ; Adler WH
    Nat Immun Cell Growth Regul; 1989; 8(4):197-208. PubMed ID: 2571927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI; Holbrook NJ; Friedman H
    J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
    Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
    No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.